Articles

  • 1 day ago | zdnet.com | Tiernan Ray

    "We're excited to become a clinical-stage biotech company; it's exciting from an AI drug discovery standpoint," says Absci founder and CEO Sean McClain. AbsciArtificial intelligence has been working its way into the drug development process for years now, but with little to show so far in revamping the notoriously burdensome process.

  • 1 day ago | flipboard.com | Tiernan Ray

    1 hour ago Elon Musk’s apparent power play at the Copyright Office completely backfired What initially appeared to be a power play by Elon Musk and the Department of Government Efficiency (DOGE) to take over the US Copyright Office by having Donald Trump remove the officials in charge has now backfired in spectacular fashion, as Trump’s acting replacements are known to be unfriendly — … Now Silicon Valley Braces for Chaos The center of the tech universe seems to believe that Trump’s tariff...

  • 1 day ago | zdnet.com | Tiernan Ray

    ebrublue10/Getty ImagesWould you trust a chatbot to answer your medical questions? If so, how would you respond to its advice? The latest research by OpenAI suggests that new releases of bots are improving in the ability to generate responses to text-based prompts about medical situations, including emergencies. It's not clear, however, how relevant all that is, since it occurs entirely as a simulated exercise, rather than real-world testing in the clinic or in an actual emergency.

  • 1 day ago | flipboard.com | Tiernan Ray

    NowThe firm, which produces content for TikTok, recorded no revenue last year, but it announced this week that a mysterious stock sale would allow it to invest heavily in the $TRUMP memecoin. A struggling technology company that has ties to China and relies on TikTok made an unusual announcement this …

  • 2 days ago | zdnet.com | Tiernan Ray

    NanoStockk / Getty ImagesThe debate over the risks and harms of artificial intelligence often focuses on what governments can or should do. However, just as important are the choices that AI researchers themselves make.

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →

X (formerly Twitter)

Followers
14K
Tweets
24K
DMs Open
Yes
Tiernan Ray
Tiernan Ray @TiernanRayTech
7 May 25

Lumentum and Arista shine despite uncertainty Cloud computing demand for fiber optics and networking is supporting healthy results at both Lumentum and Arista, but both companies are waiting to find out what happens when the tariff pause ends on July 8th. Some companies, such as https://t.co/cD3xpOeJ0x

Tiernan Ray
Tiernan Ray @TiernanRayTech
6 May 25

Palantir sells off despite everything being ‘on fire’ The valuation is insane for Palantir, but the growth numbers keep impressing. The only fly in the ointment is Europe, where they just don’t get it, according to CEO Alex Karp. https://t.co/6MQDaJePyF $PLTR https://t.co/HURxnT41T1

Tiernan Ray
Tiernan Ray @TiernanRayTech
5 May 25

Wall Street’s Best Ideas: A tariff on movies despite the U.S. trade surplus? The very vague news that the White House will impose a hundred-percent tariff on foreign movies casts a pall over Netflix, which is surprising given this is one of the few areas where the U.S. enjoys a https://t.co/wGCvl1LAs3